Inventor · disambiguated record
Jamal Tazi
Also filed as: TAZI JAMAL
38 granted patents·12 pending applications·181 citations·filing 2004–2024
97Inventor score
Files withABIVAX39CENTRE NAT RECH SCIENT3TAZI JAMAL3CENTRE NATIONALE DE RECHERCHE SCIENT1CT NATIONALE DE RECH SCIENT1
Top patents by PatentIndex Score
50 records- 0196US9145367B2Compounds useful for treating AIDSTAZI JAMAL·Filed 2010·Granted Sep 29, 2015·51 cites·18 claims
- 0295US10981874B2Use of quinoline derivatives for the treatment of inflammatory diseasesABIVAX·Filed 2019·Granted Apr 20, 2021·5 cites·22 claims
- 0394US10683284B2Compounds for preventing, inhibiting, or treating cancer, aids and/or premature agingABIVAX·Filed 2018·Granted Jun 16, 2020·7 cites·10 claims
- 0494US10253020B2Compounds for preventing, inhibiting, or treating cancer, AIDS and/or premature agingABIVAX·Filed 2017·Granted Apr 9, 2019·8 cites·13 claims
- 0593US9637475B2Compounds for treating cancerABIVAX·Filed 2015·Granted May 2, 2017·13 cites·27 claims
- 0692US10017498B2Compounds useful for treating AIDSABIVAX·Filed 2015·Granted Jul 10, 2018·9 cites·18 claims
- 0790US10435370B2Quinoline derivatives for the treatment of inflammatory diseasesABIVAX·Filed 2015·Granted Oct 8, 2019·11 cites·22 claims
- 0890US9108919B2Compounds useful for treating cancerCT NATIONALE DE RECH SCIENT·Filed 2013·Granted Aug 18, 2015·18 cites·10 claims
- 0989US9061999B2Compounds useful for treating AIDSTAZI JAMAL·Filed 2011·Granted Jun 23, 2015·17 cites·14 claims
- 1088US10718770B2Methods for screening compounds for treating or preventing a viral infection or a virus-related conditionABIVAX·Filed 2016·Granted Jul 21, 2020·4 cites·24 claims
- 1186US11649211B2Use of quinoline derivatives for the treatment of inflammatory diseasesABIVAX·Filed 2020·Granted May 16, 2023·1 cites·16 claims
- 1286US9827237B2Compounds useful for treating diseases caused by retrovirusesABIVAX·Filed 2014·Granted Nov 28, 2017·10 cites·12 claims
- 1386US2025100971A1In vitro or ex vivo methods for screening a quinoline derivativeABIVAX·Filed 2024·Application pending·0 cites
- 1484US9233931B2Chemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomaliesCENTRE NAT RECH SCIENT·Filed 2013·Granted Jan 12, 2016·5 cites·2 claims
- 1583US9969715B2Compounds useful for treating cancerABIVAX·Filed 2013·Granted May 15, 2018·5 cites·8 claims
- 1683US8604063B2Chemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomaliesTAZI JAMAL·Filed 2009·Granted Dec 10, 2013·5 cites·3 claims
- 1782US12479802B2Phenyl-n-quinoline derivatives for treating a RNA virus infectionABIVAX·Filed 2024·Granted Nov 25, 2025·0 cites·7 claims
- 1880US12202804B2In vitro or ex vivo methods for screening a quinoline derivativeABIVAX·Filed 2022·Granted Jan 21, 2025·0 cites·19 claims
- 1979US12084422B2Phenyl-n-quinoline derivatives for treating a RNA virus infectionABIVAX·Filed 2019·Granted Sep 10, 2024·1 cites·12 claims
- 2079US10717724B2Compounds useful for treating cancerABIVAX·Filed 2018·Granted Jul 21, 2020·1 cites·15 claims
- 2178US11441181B2miRNA-124 as a biomarkerABIVAX·Filed 2014·Granted Sep 13, 2022·1 cites·14 claims
- 2277US10130595B2Chemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomaliesCENTRE NATIONALE DE RECHERCHE SCIENT·Filed 2015·Granted Nov 20, 2018·3 cites·12 claims
- 2374US11649210B2Use of quinoline derivatives for the treatment of inflammatory diseasesABIVAX·Filed 2020·Granted May 16, 2023·0 cites·17 claims
- 2474US2024343716A1Compounds for preventing, inhibiting, or treating cancer, aids and/or premature agingABIVAX·Filed 2024·Application pending·0 cites
- 2573US2025275994A1Quinoline Derivatives For Use In The Treatment Of Inflammation DiseasesABIVAX·Filed 2024·Application pending·0 cites
- 2672US10975063B2Compound, and production method thereof, and methods of treatment using the compoundABIVAX·Filed 2019·Granted Apr 13, 2021·0 cites·18 claims
- 2772US9908869B2Compounds useful for treating aidsSOC SPLICOS·Filed 2014·Granted Mar 6, 2018·2 cites·25 claims
- 2871US2025032474A1Combination of 8-chloro-n-(4-(trifluoromethoxy)phenyl)quinolin-2-amine and its derivatives with a s1p receptor modulatorABIVAX·Filed 2024·Application pending·0 cites
- 2969US11992499B2Quinoline derivatives for use in the treatment of inflammation diseasesABIVAX·Filed 2019·Granted May 28, 2024·0 cites·38 claims
- 3069US9890112B2Compounds for use as therapeutic agents affecting p53 expression and/or activitySCHERRER DIDIER·Filed 2012·Granted Feb 13, 2018·2 cites·11 claims
- 3168US10329317B2Quinoline derivative for use in the treatment and prevention of viral infectionsABIVAX·Filed 2016·Granted Jun 25, 2019·1 cites·10 claims
- 3267US11014918B2Compounds and pharmaceutical compositions containing at least one of the compoundsABIVAX·Filed 2020·Granted May 25, 2021·0 cites·10 claims
- 3366US12247018B2Aryl-n-aryl derivatives for treating a RNA virus infectionABIVAX·Filed 2019·Granted Mar 11, 2025·0 cites·17 claims
- 3465US12421206B2Aryl-n-aryl derivatives for treating a RNA virus infectionABIVAX·Filed 2019·Granted Sep 23, 2025·0 cites·17 claims
- 3565US10654813B2Chemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomaliesCENTRE NAT RECH SCIENT·Filed 2018·Granted May 19, 2020·0 cites·2 claims
- 3664US2025170119A1Combination of 8-chloro-n-(4-(trifluoromethoxy)phenyl)quinolin-2-amine and its derivatives with a s1p receptor modulatorABIVAX·Filed 2023·Application pending·0 cites
- 3764US2025099454A1Combination of 8-chloro-n-(4-(trifluoromethoxy)phenyl)quinolin-2-amine and its derivatives with a jak inhibitorABIVAX·Filed 2023·Application pending·0 cites
- 3863US11427566B2Compounds useful for treating cancerABIVAX·Filed 2020·Granted Aug 30, 2022·0 cites·16 claims
- 3963US2022127253A1Compounds for preventing, inhibiting, or treating cancer, aids and/or premature agingABIVAX·Filed 2021·Application pending·0 cites
- 4061US11739073B2Aryl-n-aryl derivatives for treating a RNA virus infectionABIVAX·Filed 2019·Granted Aug 29, 2023·0 cites·21 claims
- 4156US10538485B2Compounds for use as therapeutic agents affecting P53 expression and/or activityABIVAX·Filed 2017·Granted Jan 21, 2020·0 cites·11 claims
- 4256US7989467B2Use of indole-derived compounds for the preparation of a medicament that can be used to treat diseases related to the splicing processCENTRE NAT RECH SCIENT·Filed 2004·Granted Aug 2, 2011·1 cites·13 claims
- 4356US2022071985A1Quinoline derivatives for use in the treatment or prevention of cancerABIVAX·Filed 2019·Application pending·0 cites
- 4454US2023142547A1Compounds for treating or preventing a coronaviridae infection & methods and uses for assessing the occurrence of a coronaviridae infectionABIVAX·Filed 2021·Application pending·0 cites
- 4553US2022145406A1Biomarkers, and uses in treatment of viral infections, inflammations, or cancerABIVAX·Filed 2019·Application pending·0 cites
- 4650US2023106420A1Aryl-n-aryl derivatives for treating a rna virus infectionABIVAX·Filed 2020·Application pending·0 cites
- 4749US9556489B2Use of RBM39 as a biomakerABIVAX·Filed 2013·Granted Jan 31, 2017·0 cites·16 claims
- 4841US10806729B2Quinoline derivatives for use in the treatment or prevention of viral infectionABIVAX·Filed 2016·Granted Oct 20, 2020·0 cites·15 claims
- 4941US8895726B2Compounds derived from indole and pharmaceutical compositions containing themLEJEUNE FABRICE·Filed 2008·Granted Nov 25, 2014·0 cites·19 claims
- 5035US2017197938A1A quinoline derivative for the treatment of inflammatory diseases and aidsABIVAX·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jamal Tazi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →